Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
7th January 2021 | Brian Lee Baker | 5,200 | Open or private sale | $121.57 | $632,164.00 |
7th January 2021 | Brian Lee Baker | 4,545 | Exercise of derivative | $5.12 | $23,270.40 |
7th January 2021 | Brian Lee Baker | 513 | Open or private sale | $123.02 | $63,109.26 |
7th January 2021 | Brian Lee Baker | 900 | Open or private sale | $120.16 | $108,144.00 |
7th January 2021 | Brian Lee Baker | 10,689 | Exercise of derivative | $7.43 | $79,419.27 |
7th January 2021 | Brian Lee Baker | 1,299 | Exercise of derivative | $3.20 | $4,156.80 |
7th January 2021 | Advisors Llc Orbimed | 2,000,000 | Open or private sale | $3.50 | $7,000,000.00 |
7th January 2021 | Brian Lee Baker | 11,905 | Exercise of derivative | $2.19 | $26,071.95 |
7th January 2021 | Brian Lee Baker | 2,800 | Open or private sale | $122.65 | $343,420.00 |
7th January 2021 | Brian Lee Baker | 21,825 | Open or private sale | $122.44 | $2,672,253.00 |
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
11th January 2021
11th January 2021